News

Filter

Current filters:

None

8026 to 8035 of 95930 results

NovAliX in drug discovery collaboration with Teijin Pharma

13-01-2012

French company NovAliX has entered into a multi-target integrated drug discovery collaboration with Japanese…

Asia-PacificEuropeNovAliXPharmaceuticalResearchTeijin

Licensing deal for Basilea in sight

13-01-2012

The completion of the pneumonia data audit and confirmation of the timeline for Switzerland-based Basilea’s…

Antibiotics and Infectious diseasesBasilea PharmaceuticaceftobiproleDermatologicalsLicensingPharmaceuticalResearchToctino

FDA gives Hemispherx time to respond to CRL

12-01-2012

Shares of USA-based Hemispherx Biopharma (NYSE Amex: HEB) rose 14% to $0.24 on Wednesday, after the company…

AmpligenHemispherx BioPharmaImmunologicalsNorth AmericaPharmaceuticalRegulation

GlaxoSmithKline challenges Argentina court ruling

12-01-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) says it disagrees with the recent court ruling in favor of…

FinancialGlaxoSmithKlineLegalPharmaceuticalSouth AmericaSynflorixVaccines

Covance links with Inserm on R&D

12-01-2012

USA-based contract research organization Covance (NYSE: CVD) has signed a four-year scientific collaboration…

CovanceEuropeInsermPharmaceuticalResearch

Revisions to Code of Marketing for Ireland’s pharma

12-01-2012

The Irish Pharmaceutical Healthcare Association (IPHA) this week announced the introduction of a revised…

EuropeMarkets & MarketingPharmaceuticalRegulation

US ANDAs filed for generic Beyaz, Isentress and Epivir

12-01-2012

The US Food and Drug Administration says that Abbreviated New Drug Applications have been received by…

Anti-viralsBayerBeyazEpivirGenericsGlaxoSmithKlineIsentressMerck & CoPharmaceuticalRegulationReproductive

Negative NICE guidance for Sanofi prostate cancer drug

12-01-2012

The UK’s drug watchdog the National Institute for Health and Clinical Excellence (NICE), has today…

EuropeJevtanaOncologyPharmaceuticalPricingRegulationSanofi

Merck & Co out to lead in hepatitis C

12-01-2012

US drugs giant Merck & Co (NYSE: MRK) aims to become a leader in the hepatitis C space, the company’s…

Anti-viralsMerck & CoMergers & AcquisitionsPharmaceuticalResearch

8026 to 8035 of 95930 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top